- Home
- / Strongbridge Biopharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Strongbridge Biopharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$30.7 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 19, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|---|---|---|
| Revenue | 7.0M | 18.0M | 21.7M | 30.7M | ||
| Cost of goods sold | 1.5M | 4.0M | ||||
| Gross profit | 5.6M | 14.0M | ||||
| Gross profit margin, % | 79.0% | 77.9% | ||||
| General and administrative expense | 22.7M | 14.9M | 36.3M | 63.3M | 49.1M | 40.9M |
| Operating expense total | 42.9M | 50.7M | 79.3M | 96.0M | 80.0M | 66.7M |
| Depreciation and amortization | 5.0M | 7.2M | 5.0M | 5.0M | ||
| EBIT | (42.9M) | (50.7M) | (73.7M) | (81.9M) | (67.1M) | (43.2M) |
| EBIT margin, % | -1046.6% | -454.4% | -309.0% | -140.5% | ||
| Pre tax profit | (44.1M) | (51.4M) | (111.7M) | 32.4M | (47.7M) | (45.1M) |
| Income tax expense | (450.0K) | (2.6M) | 1.8M | 536.0K | 1.8M | (15.0K) |
| Net Income | (43.6M) | (48.7M) | (113.5M) | 31.9M | (49.5M) | (45.1M) |